BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25634359)

  • 1. NKG2D-dependent activation of dendritic epidermal T cells in contact hypersensitivity.
    Nielsen MM; Dyring-Andersen B; Schmidt JD; Witherden D; Lovato P; Woetmann A; Ødum N; Poulsen SS; Havran WL; Geisler C; Bonefeld CM
    J Invest Dermatol; 2015 May; 135(5):1311-1319. PubMed ID: 25634359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of an NKG2D ligand H60c in epidermal dendritic T cell-mediated wound repair.
    Yoshida S; Mohamed RH; Kajikawa M; Koizumi J; Tanaka M; Fugo K; Otsuka N; Maenaka K; Yagita H; Chiba H; Kasahara M
    J Immunol; 2012 Apr; 188(8):3972-9. PubMed ID: 22403443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic Epidermal T Cells in Allergic Contact Dermatitis.
    Mraz V; Geisler C; Bonefeld CM
    Front Immunol; 2020; 11():874. PubMed ID: 32508820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin.
    Whang MI; Guerra N; Raulet DH
    J Immunol; 2009 Apr; 182(8):4557-64. PubMed ID: 19342629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1β-dependent activation of dendritic epidermal T cells in contact hypersensitivity.
    Nielsen MM; Lovato P; MacLeod AS; Witherden DA; Skov L; Dyring-Andersen B; Dabelsteen S; Woetmann A; Ødum N; Havran WL; Geisler C; Bonefeld CM
    J Immunol; 2014 Apr; 192(7):2975-83. PubMed ID: 24600030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKG2D ligation without T cell receptor engagement triggers both cytotoxicity and cytokine production in dendritic epidermal T cells.
    Nitahara A; Shimura H; Ito A; Tomiyama K; Ito M; Kawai K
    J Invest Dermatol; 2006 May; 126(5):1052-8. PubMed ID: 16484989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2D triggers cytotoxicity in murine epidermal γδ T cells via PI3K-dependent, Syk/ZAP70-independent signaling pathway.
    Ibusuki A; Kawai K; Yoshida S; Uchida Y; Nitahara-Takeuchi A; Kuroki K; Kajikawa M; Ose T; Maenaka K; Kasahara M; Kanekura T
    J Invest Dermatol; 2014 Feb; 134(2):396-404. PubMed ID: 23962808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.
    Weinger JG; Plaisted WC; Maciejewski SM; Lanier LL; Walsh CM; Lane TE
    Stem Cells; 2014 Oct; 32(10):2690-701. PubMed ID: 24898518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
    Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation.
    Li J; Zhu H; Wang S; Ye P; Liu C; Wu J; Xia J
    Transplantation; 2012 Feb; 93(4):356-63. PubMed ID: 22179404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine oxidoreductase is required for genotoxic stress-induced NKG2D ligand expression and gemcitabine-mediated antitumor activity.
    Xu X; Rao G; Li Y
    Oncotarget; 2016 Sep; 7(37):59220-59235. PubMed ID: 27494876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of NKG2D and its ligands RAE-1 and H60 on graft-versus-tumor response].
    Li XF; Chen Q; Ye YB; Fan LF; Chen MS; Li JY; Chen HQ; Chen SP; Zhou ZF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):160-4. PubMed ID: 17490545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.
    Matsumoto K; Obana M; Kobayashi A; Kihara M; Shioi G; Miyagawa S; Maeda M; Sakata Y; Nakayama H; Sawa Y; Fujio Y
    Cardiovasc Res; 2019 Mar; 115(4):765-775. PubMed ID: 30307485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection.
    Feng L; Ke N; Ye Z; Guo Y; Li S; Li Q; Li Y
    Transplant Proc; 2009 Dec; 41(10):4332-9. PubMed ID: 20005394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKG2D-independent suppression of T cell proliferation by H60 and MICA.
    Kriegeskorte AK; Gebhardt FE; Porcellini S; Schiemann M; Stemberger C; Franz TJ; Huster KM; Carayannopoulos LN; Yokoyama WM; Colonna M; Siccardi AG; Bauer S; Busch DH
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11805-10. PubMed ID: 16091471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells.
    Sauer M; Schuldner M; Hoffmann N; Cetintas A; Reiners KS; Shatnyeva O; Hallek M; Hansen HP; Gasser S; von Strandmann EP
    Oncogene; 2017 Feb; 36(7):933-941. PubMed ID: 27477692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.
    Spada R; Rojas JM; Pérez-Yagüe S; Mulens V; Cannata-Ortiz P; Bragado R; Barber DF
    J Leukoc Biol; 2015 Mar; 97(3):583-98. PubMed ID: 25583577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 4 engagement contributes to expression of NKG2D ligands by renal tubular epithelial cells.
    Chen GE; Wu H; Ma J; Chadban SJ; Sharland A
    Nephrol Dial Transplant; 2011 Dec; 26(12):3873-81. PubMed ID: 21555390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.